Explore our blog
Cellular Therapies in Hematologic Malignancies: Trends & Market Access Implications Across Care Settings
Madeline Waldron, PharmD, BCOP | Vice President, Clinical Oncology Solutions
.jpeg)
5 Takeaways from JPM That Will Shape 2026
Greg Gregory, PhD | Executive Vice President, Partner, Precision AQ Hannah Deresiewicz | EVP, Managing Director,...
Turning Clinical Breakthroughs Into Payer- Ready Value Stories
Stephanie Spence, PharmD, CSP, Senior Director, Access Experience Team